Gelonghui July 12?Qianhai Health (00911.HK) noticeGroup expectationSix months ended June 30, 2023The net loss attributable to shareholders was approximately HK $110 million, compared with the net profit attributable to shareholders of approximately HK $20 million for the six months ended 30 June 2022 (the "previous period").
The change from profit to loss during the period is mainly due to the combined effects of: (I) the change from gross profit in the previous period to gross loss in the current period is due to a significant decrease of about 72% in the current period compared with the previous period, as the market price of electronic components (especially semiconductors) fell further by about 25-54% during the period. (ii) the provision of approximately HK $17 million for the reversal of loss contracts for supplier products during the period was due to the delivery of some supplier products to the Group during the period; and (iii) confirmed that the inventory provision of approximately HK $113 million was due to a further decline in the market price of inventories (including delivered products) as mentioned above.